Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.405ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.405ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.405NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.282ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.282ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.282ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.282NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.228ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.228ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.228ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.228NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.174ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.174ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.174ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.174NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.88 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.88 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.88 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.88 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.106 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.106 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.106 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.106 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.346ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.346ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.346ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.346NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.93ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.93ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.93ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.93NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.512ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CP.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CP.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.39ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.39NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.40ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.40ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.40NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.3.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.3.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BM.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BM.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used